Pregnant Women, New Moms Dying More Often From Heart Conditions
By Dennis Thompson HealthDay Reporter
TUESDAY, April 1, 2025 -- The heart-related death rate among pregnant women and new mothers more than doubled between 1999 and 2022, researchers have found.
Just under 9.1 mothers for every million people died from heart-related diseases in 2022, up from 3.6 per million in 1999, according to results presented Sunday at the American College of Cardiology’s annual meeting in Chicago.
Black women and women living in Southern states are at the highest risk, researchers found.
“We’re heading in the wrong direction,” lead researcher Dr. Mohammad Ahabab Hossain, a resident physician at Rutgers New Jersey Medical School in Newark, N.J., said in a news release.
“The United States is supposed to be a global leader in advancing health and medicine, and the fact that we still have pregnant women who are dying — often because of preventable causes — should sound alarm bells,” he said.
The new study looked at maternal mortality, or deaths that occur when a woman is pregnant or has recently given birth. It may include deaths that occur up to a year following delivery, if the cause of death is linked to pregnancy.
For the study, researchers analyzed U.S. Centers for Disease Control and Prevention data collected between 1999 and 2022 on women of reproductive age, 15 to 44, who died of heart-related causes.
Causes could include high blood pressure, dangerous blood clots, or conditions that weakened the heart’s pumping ability, researchers said.
The data showed especially high maternal death rates in 2020 and 2021, during the COVID-19 pandemic, with a peak of 10.5 deaths per million in 2021. This could be due to limited access to prenatal care or a hesitancy to visit medical clinics during lockdowns, researchers said.
Black women had about three times the maternal death rate of white women, 21.9 per million versus 7.1 per million, results show.
Likewise, Southern women had the highest death rate compared to those from any other U.S. region – 12.1 per million, compared to 5.4 per million in Western states.
Social and economic disadvantages, limited access to health care and more widespread heart health risk factors likely drive these higher rates in maternal deaths, researchers speculated.
“Part of the reason this is happening is because heart disease and hypertension are becoming more and more prevalent, as are the conditions that are connected to heart disease, like diabetes and obesity. As a result, we wind up with more high-risk pregnancies,” Hossain said.
“However, a lot of this is preventable,” he added. “If a patient has a history of hypertension or other preexisting cardiovascular disease, that patient should be connected with a high-risk obstetrics clinic to receive the care they need.”
Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-02 00:00
Read more

- ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
- Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
- FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
- Local Outbreaks Can Motivate The Vaccine-Hesitant, Poll Finds
- New Surgical Technique Preserves Erectile Function In Prostate Cancer Patients
- USDA Disbands Two Key Food Safety Committees
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions